Asian LRRK2 variants do not increase Likelihood Ratios derived from MDS prodromal Parkinson’s Disease criteria in a community population
Objective: To determine if the presence of the Asian LRRK2 risk variants (G238R, S1647T, R1628P) confers an increased risk in developing PD in a Singaporean…Utilizing Speech Analysis to Differentiate Progressive Supranuclear Palsy from Parkinson Disease
Objective: To differentiate Progressive Supranuclear Palsy (PSP) from Parkinson Disease (PD) using speech analysis. Background: PD and PSP exhibit many clinical similarities including speech disorders…Narcolepsy type 1, supranuclear vertical gaze palsy, and agrypnia excitata in a patient with anti-Ma associated encephalitis.
Objective: To describe a case of a patient with narcolepsy type 1, supranuclear vertical gaze palsy, and agrypnia excitata, who presented with anti-Ma encephalitis. Background:…Intercultural differences in patient and clinician perceptions of MDS-UPDRS in Parkinson’s disease
Objective: To explore culturally dependent differences between patient- and clinician-based evaluations of Parkinson’s disease (PD) motor symptoms. Background: Effects of multiple demographic factors on Movement…Jerky dystonic hand revisited: post-stroke thalamic tremor
Objective: To assess phenomenology and clinical- radiological correlation of post thalamic stroke movement disorders (MDs) Background: Post stroke movement disorders (PSMD) are rare and have…Psilocybin therapy for depression and anxiety associated with Parkinson’s disease: a pilot study (NCT04932434)
Objective: To investigate the safety, tolerability, feasibility, and preliminary efficacy of moderate and high dose psilocybin treatment with psychotherapeutic support for comorbid Parkinson's disease (PD)…Deep brain stimulation for movement disorders: Assessing disparities in access to care
Objective: To investigate the impact of non-disease related factors (sex, race, age, language, or socioeconomic status) on the likelihood of movement disorders patients receiving Deep…Clinic versus home dose optimization of apomorphine sublingual film in Parkinson’s Disease: cross-study comparison of safety
Objective: To compare the safety profile of clinic versus home dose optimization of apomorphine sublingual film (SL-APO) in patients with Parkinson’s disease experiencing OFF episodes.…Therapeutic Plasma Exchange in the Management and Outcome of Stiff-Person Syndrome: A Systematic Review
Objective: In this review article, we'll explore TPE's role in treating Stiff Person Syndrome(SPS) and its outcomes. Background: Rigidity, stiffness, and intermittent spasms of the…Serum Zinc Deficiency could be associated with dementia conversion in Parkinson’s disease
Objective: To investigate the role of depletion or excess of various heavy metals on clinical characteristics of Parkinson's disease (PD) developing PD dementia in drug-naïve…
- « Previous Page
- 1
- …
- 182
- 183
- 184
- 185
- 186
- …
- 1554
- Next Page »